Notice for pegvaliase (BioMarin Pharmaceuticals Australia Pty Ltd)
Active ingredients
pegvaliase
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for Injection
Indication
Treatment of hyperphenylalaninemia (HPA) due to phenylketonuria (PKU).
Therapeutic area
Inherited metabolic disorders